The cancer treatment/immuno-oncology market is expansive and ripe with potential for long-term healthcare investors. Predictably, there are significant implications for biotechnology and genomics companies. That highlights long-term opportunity with exchange traded funds such as the ARK Genomic Revolution ETF (ARKG). In fact, ARKG could, over time, prove to be highly relevant in this conversation because [...] The post ARKG: Smart Idea for Smart Advancements in Cancer Treatment appeared first on ETF Trends .